Immune 'signature' unique to Ebola fatalities identified by scientists

Recognising difference in immune response between survivors and fatalities raises hope that current anti-cancer drug could be used to treat Ebola patients

Scientists have identified a key feature in the human immune system that determines whether someone will live or die from Ebola.

The breakthrough research brings hope that existing anti-cancer treatments could be used to treat the virus, which killed almost 12,000 in the recent epidemic in West Africa.